We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nex Group | LSE:NXG | London | Ordinary Share | GB00BZ02MH16 | ORD 17.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,129.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/10/2018 14:59 | Heads up for anyone still holding here. Deal completes tomorrow, cash into accounts within 14 days. | jeffian | |
04/7/2018 10:52 | Anyone know the timetable for the deal? The details of the Scheme of Arrangement say the Court hearing which triggers payments etc is "a date expected to be in the second half of 2018". | jeffian | |
21/5/2018 16:08 | Seems to be a US company traded on Nasdaq? I don't have any experience of directly-held (as opposed to in managed funds) US stocks. Is this a problem? Are they easily tradable via the usual platforms? (I'm with HL). | jeffian | |
20/5/2018 22:11 | The offer document suggests that the offer is financially attractive to CME shareholders, hence suggesting CME share price will improve in the medium/long term. The value to current Nex shareholders is also exposed to currency fluctuations. For example the 1000p offer was based on an exchange rate of 1.4101 $/£ wherasa the current exchange rate is about 1.347 increasing the UK value of the 500p CME share component by about 5% to give a total value of the offer of about 1025p | aberdeed | |
11/5/2018 09:58 | I'll take that as a 'no', then! | jeffian | |
10/5/2018 16:00 | Anyone got a view on whether the new CME shares will be worth holding? | jeffian | |
10/5/2018 14:35 | New offer is on the table wait and see | scoble2 | |
02/5/2018 19:02 | Thanks Sandlab. Not sure what drove the price today? | ph1ts | |
25/4/2018 10:35 | //www.nex.com/offer and scroll down after accepting the disclaimer... | sandlab | |
25/4/2018 10:28 | Anyone seen the Scheme Document yet? | ph1ts | |
06/4/2018 06:08 | I think the price now reflects the slight rise of the Cme price. | badgeman | |
05/4/2018 19:14 | Above the offer price, so another bidder? | rayrac | |
29/3/2018 12:25 | I don't think it is a done deal. Another offer may come from an unexpected direction. | gregsc | |
29/3/2018 07:47 | Agreed, surprised its not all cash.Questions is will counter bidders step in now. | miti 1000 | |
29/3/2018 07:03 | Looks like a done deal- perhaps some disappointment that it's not all cash? | badgeman | |
28/3/2018 17:08 | Bid discussions confirmed at 10 quid a share...should start a proper bidding war.Would hope we will eventually see over £11.50-12.00 quid a share with so many huge players interested in securing a prime asset. | miti 1000 | |
28/3/2018 14:39 | FT talking about £10 per share. But bound to be other bidders who will come in and not let CME have a tight grip on the market. | dins1249 | |
28/3/2018 14:29 | Thanks Liam. wondered where you found that info? £4bn values at roughly £10.5 a share. | relliott10 | |
28/3/2018 13:49 | CME Is Said to Near Accord on $5.7 Billion Takeover of NEX *CME IS SAID TO OFFER ABOUT 4 BILLION POUNDS FOR NEX GROUP | liam1om | |
21/3/2018 17:37 | It seems the market is pricing in a bid between 950p - 1000p imo, and there is a >90% chance of a bid materialising. Will another bidder emerge? It would certainly make things interesting. Gla. :-) | hyden | |
21/3/2018 14:20 | I wonder how this new value of the company at around £9.00 has been decided by the market? The longer it goes on for the more it becomes a base that they would have to offer a premium above. | ph1ts | |
16/3/2018 08:35 | Not bad, not bad. | sirrux | |
02/3/2018 18:18 | Looking good again. | ph1ts | |
01/2/2018 09:01 | Nice, good focus on the future while others operate in the past. | sirrux |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions